Snus is a smokeless tobacco product, widely used among Swedish men and increasingly so elsewhere. There is debate as to whether snus is an acceptable "harm-reduction" tobacco product. Since snus use delivers a dose of nicotine equivalent to cigarettes, and has been implicated in cardiac arrhythmia because of associations with sudden cardiovascular death, a relation with atrial fibrillation is plausible and important to investigate
Cardiovascular safety is an important consideration in the debate on the benefits versus the risks o...
Background The relationship between smoking and an increased incidence of cardiovascular diseases is...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...
Previous investigations of snus use (oral moist snuff, a Swedish form of smokeless tobacco) and card...
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is comm...
Background: Cigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whet...
Snus is a smokeless tobacco product made of a moist powder of ground tobacco. It is used mainly in t...
Background. Snus is a moist smokeless tobacco product with high nicotine content. Its use has a shor...
The use of Swedish oral moist snuff, known as snus, has for a long time been limited to the Scandina...
Limited data are available on the carcinogenicity of smokeless tobacco products in organs other than...
<div><p>Introduction</p><p>The use of Swedish oral moist snuff, known as snus, has for a long time b...
This is a review paper on the usage of smokeless tobacco, snus. A narrative view of published papers...
Use of snus is most prevalent in Nordic countries, and especially in Sweden, where 18% of men and 3%...
ABSTRACT In excess of 10% of the Norwegian population are snus-users, and the proportion is increas...
AbstractReviews show that using snus (Swedish-type moist snuff) is much safer than smoking, with no ...
Cardiovascular safety is an important consideration in the debate on the benefits versus the risks o...
Background The relationship between smoking and an increased incidence of cardiovascular diseases is...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...
Previous investigations of snus use (oral moist snuff, a Swedish form of smokeless tobacco) and card...
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is comm...
Background: Cigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whet...
Snus is a smokeless tobacco product made of a moist powder of ground tobacco. It is used mainly in t...
Background. Snus is a moist smokeless tobacco product with high nicotine content. Its use has a shor...
The use of Swedish oral moist snuff, known as snus, has for a long time been limited to the Scandina...
Limited data are available on the carcinogenicity of smokeless tobacco products in organs other than...
<div><p>Introduction</p><p>The use of Swedish oral moist snuff, known as snus, has for a long time b...
This is a review paper on the usage of smokeless tobacco, snus. A narrative view of published papers...
Use of snus is most prevalent in Nordic countries, and especially in Sweden, where 18% of men and 3%...
ABSTRACT In excess of 10% of the Norwegian population are snus-users, and the proportion is increas...
AbstractReviews show that using snus (Swedish-type moist snuff) is much safer than smoking, with no ...
Cardiovascular safety is an important consideration in the debate on the benefits versus the risks o...
Background The relationship between smoking and an increased incidence of cardiovascular diseases is...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...